Intracellular signals triggered during association of Mycobacterium leprae and Mycobacterium bovis BCG with human monocytes

被引:9
|
作者
Lima, CS [1 ]
Ribeiro, ML [1 ]
Souza, LA [1 ]
Sardella, AB [1 ]
Wolf, VMA [1 ]
Pessolani, MCV [1 ]
机构
[1] FIOCRUZ, Fdn Oswaldo Cruz, Inst Oswaldo Cruz, Lab Hanseniase, BR-21405000 Rio De Janeiro, RJ, Brazil
关键词
Mycobactrium leprae; adherence; phagocytosis; human monocytes; signalling pathways; Mycobacterium bovis BCG;
D O I
10.1006/mpat.2001.0444
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To gain a better understanding of mycobacteria-host cell interaction, the present study compared the signal transduction events triggered during the interaction of Mycobacterium leprae (the causative agent of leprosy) and of Mycobacterium bovis BCG (an attenuated strain used as a vaccine against leprosy and tuberculosis) with human monocytes. The assays consisted of pretreating or not THP-1 cells (a human monocytic cell line) with different kinase inhibitors, followed by incubation with fluorescein-labelled bacteria and analysis of bacterial association via fluorescence microscopy. The specific tyrosine kinase (TK) inhibitor tyrphostin AG126 provided the highest rates of association inhibition (> 90% for BCG and > 65% for M. leprae). The early activation of TKs during mycobacteria-host cell interaction was confirmed by immunoblot analysis, demonstrating that in several host cell proteins mycobacteria stimulated tyrosine phosphorylation. The use of the drugs wortmannin and bisindolylmaleimide I which, respectively, inhibit phosphatidylinositide 3-kinase (PI 3-kinase) and protein kinase C (PKC), produced lower but consistent results within a 35-60% association inhibition range for both bacteria. Dose response curves with these inhibitors were obtained. Similar results were obtained when primary human monocytes were used as host cells, strongly suggesting that TK, PKC and PI 3-kinase signals are activated during the interaction of human monocytes with both pathogenic and attenuated species of mycobacteria. (C) 2001 Academic Press.
引用
收藏
页码:37 / 45
页数:9
相关论文
共 50 条
  • [41] Mycobacterium bovis BCG binds factor H
    Aziz, M. Abdul
    Carroll, M.
    Sim, R. B.
    Sim, E.
    IMMUNOLOGY, 2011, 135 : 86 - 86
  • [42] Auxotrophic Mycobacterium bovis BCG: Updates and Perspectives
    Dellagostin, Odir Antonio
    Borsuk, Sibele
    Oliveira, Thais Larre
    Seixas, Fabiana Kommling
    VACCINES, 2022, 10 (05)
  • [43] Mycobacterium bovis BCG in metastatic melanoma therapy
    Martha Lucia Ruiz Benitez
    Camila Bonnemann Bender
    Thaís Larré Oliveira
    Kyle M. Schachtschneider
    Tiago Collares
    Fabiana Kömmling Seixas
    Applied Microbiology and Biotechnology, 2019, 103 : 7903 - 7916
  • [44] Immunosorbents for the preparation of Mycobacterium bovis BCG antigen
    Krejcikova, S
    Benes, MJ
    Wisingerova, E
    Turkova, J
    COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1996, 61 (12) : 1823 - 1830
  • [45] Mycobacterium bovis BCG in metastatic melanoma therapy
    Ruiz Benitez, Martha Lucia
    Bender, Camila Bonnemann
    Oliveira, Thais Larre
    Schachtschneider, Kyle M.
    Collares, Tiago
    Seixas, Fabiana Koemmling
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2019, 103 (19) : 7903 - 7916
  • [46] Mycobacterium leprae Phenolglycolipid-1 Expressed by Engineered M. bovis BCG Modulates Early Interaction with Human Phagocytes
    Tabouret, Guillaume
    Astarie-Dequeker, Catherine
    Demangel, Caroline
    Malaga, Wladimir
    Constant, Patricia
    Ray, Aurelie
    Honore, Nadine
    Bello, Nana Fatimath
    Perez, Esther
    Daffe, Mamadou
    Guilhot, Christophe
    PLOS PATHOGENS, 2010, 6 (10)
  • [47] MRP8/14 induces autophagy to eliminate intracellular Mycobacterium bovis BCG
    Wang, Jinli
    Huang, Chunyu
    Wu, Minhao
    Zhong, Qiu
    Yang, Kun
    Li, Miao
    Zhan, Xiaoxia
    Wen, Jinsheng
    Zhou, Lin
    Huang, Xi H
    JOURNAL OF INFECTION, 2015, 70 (04) : 415 - 426
  • [48] T cells and cytokines in intracellular bacterial infections: Experiences with Mycobacterium bovis BCG - Discussion
    Kaufmann, SHE
    Liew, FY
    Sher, A
    Mitchison, NA
    Ramshaw, IA
    Flavell, R
    Coffman, RL
    Lotze, MT
    Romagnani, S
    Abbas, AK
    Locksley, RM
    Allen, PM
    T CELL SUBSETS IN INFECTIOUS AND AUTOIMMUNE DISEASES, 1995, 195 : 132 - 136
  • [49] Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
    Harboe, M
    Oettinger, T
    Wiker, HG
    Rosenkrands, I
    Andersen, P
    INFECTION AND IMMUNITY, 1996, 64 (01) : 16 - 22
  • [50] Catalase-peroxidase of Mycobacterium bovis BCG converts isoniazid to isonicotinamide, but not to isonicotinic acid:: Differentiation parameter between enzymes of Mycobacterium bovis BCG and Mycobacterium tuberculosis
    Kang, Sung-Koo
    Lee, Jong-Ho
    Lee, Young-Choon
    Kim, Cheorl-Ho
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (05): : 724 - 729